First, we found from the data that the ABCB1-overexpressing KB-V1 human epidermal cancer cells were significantly resistant to HS-173 treatment (RF = 11) as compared to the parental KB-3-1 cancer cells (Figure 1A). This evidence concerns the gene ABCB1 and cancer.